Maurizio Zucco

Statistics

Publications

Citations

349

H-Index

Active since

2022

Affiliations

Vita-Salute San Raffaele University(Current)

IRCCS Ospedale San Raffaele

San Raffaele University of Rome

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Istituti di Ricovero e Cura a Carattere Scientifico

Maurizio Zucco is an author at Vita-Salute San Raffaele University specializing in headache disorders, headache assessment, and migraine pharmacology.

Publications per year

2022–2024

Publications

Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2022 · 117 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2022 · 103 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Late Response to Anti-CGRP Monoclonal Antibodies in Migraine

Piero Barbanti, Cinzia Aurilia, Gabriella Egeo et al. · Neurology · 2023 · 64 citations · Full text

Pharmacy, Neurology, Pharmacology +17

Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

Piero Barbanti, Cinzia Aurilia, Gabriella Egeo et al. · Journal of Neurology · 2024 · 34 citations · Full text

Life Sciences, Neurology, Pharmacology +17

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study

Piero Barbanti, Gabriella Egeo, Stefania Proietti et al. · Neurology and Therapy · 2024 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

1–5 of 6